MENU
+Compare
XLV
ETF ticker: NYSE ARCA
AS OF
Aug 12, 02:08 PM (EDT)
Price
$130.64
Change
+$0.35 (+0.27%)
Net Assets
31.84B

XLV stock forecast, quote, news & analysis

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index... Show more

Category: #Health
XLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for XLV with price predictions
Aug 11, 2025

XLV in downward trend: 10-day moving average crossed below 50-day moving average on August 06, 2025

The 10-day moving average for XLV crossed bearishly below the 50-day moving average on August 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on XLV as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for XLV turned negative on July 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

XLV moved below its 50-day moving average on July 31, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XLV entered a downward trend on August 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .

XLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Abbott Laboratories (NYSE:ABT), Merck & Co (NYSE:MRK), Intuitive Surgical (NASDAQ:ISRG), Amgen (NASDAQ:AMGN), Boston Scientific Corp (NYSE:BSX), Gilead Sciences (NASDAQ:GILD).

Industry description

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Market Cap

The average market capitalization across the The Health Care Select Sector SPDR® ETF ETF is 77.1B. The market cap for tickers in the group ranges from 7.33B to 569.45B. LLY holds the highest valuation in this group at 569.45B. The lowest valued company is CRL at 7.33B.

High and low price notable news

The average weekly price growth across all stocks in the The Health Care Select Sector SPDR® ETF ETF was 12%. For the same ETF, the average monthly price growth was 22%, and the average quarterly price growth was 41%. VTRS experienced the highest price growth at 10%, while VRTX experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the The Health Care Select Sector SPDR® ETF ETF was -16%. For the same stocks of the ETF, the average monthly volume growth was 17% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 64
Price Growth Rating: 51
SMR Rating: 56
Profit Risk Rating: 70
Seasonality Score: -35 (-100 ... +100)
View a ticker or compare two or three
XLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
One Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com